The bioactivity of plasma factors in focal segmental glomerulosclerosis

Nephron - Experimental Nephrology

Volumn 104, Issue 1, 2006, Pages

  Marszal, Joanna ^a   Saleem, Moin A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Focal segmental glomerulosclerosis; Nephrin; Plasma exchange; Plasma factors; Podocin; Podocyte

Indexed keywords

CADHERIN; CD2 ASSOCIATED PROTEIN; NEPHRIN; PODOCIN; PROTEIN ZO1;

ACTIN FILAMENT; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; KIDNEY FAILURE; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PLASMA FACTOR; PLASMAPHERESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEINURIA; SHORT SURVEY;

ANIMALS; BIOLOGICAL FACTORS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; NEPHROTIC SYNDROME; PERMEABILITY; PODOCYTES;

EID: 33747266807     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093259     Document Type: Short Survey

References (26)

1. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307.
2. Pollak MR: The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 2003;23:141-146.
3. Dragovic D, Rosenstock JL, Wahl SJ, Panagopoulos G, DeVita MV, Michelis MF: Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin Nephrol 2005;63:1-7.
4. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005;308:1801-1804.
5. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR: TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005;37:739-744.
6. Kim BK, Hong HK, Kim JH, Lee HS: Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis 2002;40:964-973.
7. Hingorani SR, Finn LS, Kowalewska J, McDonald RA, Eddy AA: Expression of nephrin in acquired forms of nephrotic syndrome in childhood. Pediatr Nephrol 2004;19:300-305.
8. Patrakka J, Ruotsalainen V, Ketola I, Holmberg C, Heikinheimo M, Tryggvason K, Jalanko H: Expression of nephrin in pediatric kidney diseases. J Am Soc Nephrol 2001;12:289-296.
9. Saleem MA, Ni L, Witherden I, Tryggvason K, Ruotsalainen V, Mundel P, Mathieson PW: Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation. Am J Pathol 2002;161:1459-1466.
10. Shalhoub RJ: Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974;2:556-560.
11. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999:68:635-641.
12. Le Berre L, Godfrin Y, Lafond-Puyet L, Perretto S, Le Carrer D, Bouhours JF, Soulillou JP, Dantal J: Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria. Kidney Int 2000;58:2502-2511.
13. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334:878-883.
14. Sharma M, Sharma R, McCarthy ET, Savin VJ: 'The FSGS factor:' enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999;10:552-561.
15. Sharma M, Sharma R, McCarthy ET, Savin VJ: The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med (Maywood) 2004;229:85-98.
16. Glassock RJ: Circulating permeability factors in the nephrotic syndrome: a fresh look at an old problem. J Am Soc Nephrol 2003;14:541-543.
17. Cattran D, Neogi T, Sharma R, McCarthy ET, Savin VJ: Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 2003;14:448-453.
18. Franz S FC, Mundel P: Cyclosporin protects podocyte stress fibers through stabilisation of synaptopodin protein expression. J Am Soc Nephrol 2005;16:109A.
19. Sharma R, Sharma M, McCarthy ET, Ge XL, Savin VJ: Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 2000;58:1973-1979.
20. Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri GM: Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002;13:1946-1952.
21. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002;13:630-638.
22. Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, Harper SJ, Mathieson PW, Saleem MA: Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 2005;16:629-637.
23. Trouet D LR, Ni L, Mathieson PW, Saleem MA: Downregulation of TRPC6 by intact nephrin in the presence of human plasma - a protective mechanism for the maintenance of podocyte foot process structure. J Am Soc Nephrol 2005;16:433A.
24. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Borner C, Pavenstadt H, Shaw AS, Walz G, Benzing T: Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003;23:4917-4928.
25. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ: Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 2003;284:F1263-F1273.
26. Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW: Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002;13:544-550.